NDC 24979-0160-44
mycophenolic acid 180 mg/1 TABLET, DELAYED RELEASE
Available — 2-Day Shipping
NDC
24979-0160-44
Generic Name
mycophenolic acid
Brand Name
mycophenolic acid
Strength
180 mg/1
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Package Size
—
Labeler
Upsher-Smith Laboratories, LLC
FDA Drug Information
Indications & Usage
1 INDICATIONS AND USAGE Mycophenolic acid delayed-release tablets are an antimetabolite immunosuppressant indicated for prophylaxis of organ rejection in adult patients receiving kidney transplants and in pediatric patients at least 5 years of age and older who are at least 6 months post kidney transplant. ( 1.1 ) Use in combination with cyclosporine and corticosteroids. ( 1.1 ) Limitations of Use: Mycophenolic acid delayed release tablets and mycophenolate mofetil tablets and capsules should no…
Source: FDA. For professional use only. Not a substitute for prescribing information.
View Product Detail →
See full specifications, request 2-day shipping, and create account to view pricing
All mycophenolic acid Strengths & Forms →
Compare all available NDC codes, strengths, and manufacturers
Other mycophenolic acid NDC Codes
Wholesale and compliance resources
DSCSA compliance resource hubRead practical guidance for authorized partners, records, and traceability.Transaction information and statementsLearn about the records that accompany pharmaceutical transfers.ScriptTrack medication workflow softwareExplore the included starter workflow for verified businesses.
Order NDC 24979-0160-44 at Wholesale
Create a free Premier Pharma account to unlock live wholesale pricing and place orders with same-day fulfillment and full DSCSA T2 documentation (TI + TS).